Discovery Park in Kent has recently welcomed two emerging biotechnology companies, MilaK and iLoF, to its CoLab facility. MilaK specializes in precision fermentation protein production, particularly animal-free whey protein, while iLoF is a digital health company focusing on personalized drug development. These companies have chosen to establish their laboratory and office spaces at the CoLab, a shared facility managed in collaboration with Canterbury Christ Church University.
MilaK, supported by Innovate UK, is currently in the research and development phase, aiming to penetrate the sports nutrition market initially and later expand into areas like infant formula and clinical nutrition. With a rapidly growing team of seven individuals, including two recently appointed scientists, MilaK is leveraging the cutting-edge laboratory facilities and collaborative environment at Discovery Park to accelerate their research timelines. Founder Milena Hutchings highlighted the importance of the infrastructure and collaborative opportunities offered by the site in their decision-making process.
On the other hand, iLoF, known as Intelligent Lab on Fiber, is focused on enhancing the efficiency of clinical and pre-clinical trials through the integration of artificial intelligence and proprietary optical technology. The company has secured over $10 million in funding from investors such as Microsoft Ventures and Hamamatsu Ventures Japan. iLoF’s Chief Operating Officer, Mehak Mumtaz, emphasized the rapid growth of the company and the strategic advantage of being located at Discovery Park to foster collaborations with other life science entities.
The CoLab facility at Discovery Park aims to support early-stage biotech companies by providing access to specialized equipment, flexible lease terms, and connections to the broader life sciences cluster in South East England. With the addition of MilaK and iLoF, the total number of tenants at Discovery Park has surpassed 180, encompassing sectors like biotechnology, pharmaceuticals, and advanced manufacturing. Chris Broom, the Head of Business Development at Discovery Park, commended the innovative and science-driven nature of these companies, noting their compatibility with the collaborative ecosystem at the park.
The strategic positioning of MilaK and iLoF within Discovery Park’s CoLab signifies a significant step in their growth trajectory, allowing them to tap into state-of-the-art resources, foster collaborations, and accelerate their research and development efforts. By being part of a vibrant ecosystem that encourages synergies among tenants, these companies are poised to thrive and make valuable contributions to the biotechnology landscape in the UK. The proactive approach taken by MilaK and iLoF in leveraging their new location exemplifies a strategic mindset focused on expansion, innovation, and industry collaboration.
Key Takeaways:
– The move of MilaK and iLoF into Discovery Park’s CoLab showcases the growing importance of collaborative environments in fostering innovation and accelerating research timelines in the biotechnology sector.
– Leveraging state-of-the-art facilities and collaborative opportunities at Discovery Park, these companies are well-positioned to expand their operations, tap into new markets, and establish strategic partnerships within the life sciences cluster.
– The strategic advantage of being part of a vibrant ecosystem of over 180 tenants at Discovery Park offers MilaK and iLoF the opportunity to drive growth, explore synergies, and contribute to the advancement of biotechnology in the UK.
Tags: biotech, sports, precision fermentation
Read more on vegconomist.com